IP Library Granted Patent US 10,702,627
Granted Patent B2
US 10,702,627 · App. 16/048,658 · Granted Jul 7, 2020

Solid forms for tissue repair

Inventors: Nir Altschuler (Hod Hasharon, IL); Razi Vago (Lehavim, IL)
Assignee: Cartiheal (2009) Ltd.
A61L27/025A61F2/28A61F2/30756A61L27/18A61L27/20A61L27/34A61L27/3604A61L27/3834A61L27/3847A61L27/3852A61L27/427A61L27/52A61L27/54A61L27/56A61F2/3094A61F2002/30011A61F2002/3092A61F2002/30224A61F2002/30807A61F2230/0069A61F2250/0023A61F2310/00341A61L2300/414A61L2300/606A61L2430/02A61L2430/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,702,627
App. No.
16/048,658
Granted
Jul 7, 2020
Kind
B2
Abstract

This invention provides aragonite- and calcite-based scaffolds for the repair, regeneration, enhancement of formation or a combination thereof of cartilage and/or bone, which scaffolds comprise at least two phases, wherein each phase differs in terms of its chemical content, or structure, kits comprising the same, processes for producing solid aragonite or calcite scaffolds and methods of use thereof.

Claims (36)

1. A scaffold for tissue repair, said scaffold consisting essentially of two phases wherein:

a first phase of said two phases comprises solid coral, aragonite or calcite and a biocompatible polymer,

wherein said first phase further comprises a series of hollows along a longitudinal axis in said first phase, and wherein said biocompatible polymer penetrates to within said hollows; and

a second phase of said two phases that comprises a solid coral, aragonite or calcite,

wherein said scaffold is seeded with cells that comprise bone marrow cells, precursor cells derived from adipose tissue, or a combination thereof and wherein said first phrase or said second phase of said scaffold comprises said solid form of aragonite or calcite.

2. The scaffold of claim 1 , wherein said biocompatible polymer is a natural polymer that comprises a glycosaminoglycan, or chitosan, or a combination thereof.

3. The scaffold of claim 1 , wherein said first phrase or said second phase comprises said solid coral and said coral is from the Porites species, Millepora species, or Acropora species.

4. The scaffold of claim 3 , wherein said coral is Porites Lutea.

5. The scaffold of claim 3 , wherein said coral is Millepora dichotoma.

6. The scaffold of claim 3 , wherein said coral is Acropora grandis.

7. The scaffold of claim 1 , wherein said biocompatible polymer further comprises an antiinflammatory compound, an anti-infective compound, a growth factor, a chelator, an antibiotic, a cell population other than said bone marrow cells or said precursor cells derived from adipose tissue, a pro-angiogenic factor or a combination thereof.

8. The scaffold of claim 3 , wherein said first phase of said scaffold comprises said solid coral.

9. The scaffold of claim 3 , wherein said second phase of said scaffold comprise said solid coral.

10. The scaffold of claim 1 , wherein said scaffold is a shape that accommodates a site of repair.

11. The scaffold of claim 1 , wherein said scaffold approximates the form of a cylinder, cone, screw, rectangular bar, plate, disc, pyramid, granule, ball or cube.

12. The scaffold of claim 1 , wherein said biocompatible polymer is only in said first phase.

13. The scaffold of claim 2 , wherein said natural polymer comprises chitosan.

14. The scaffold of claim 2 , wherein said biocompatible polymer comprises said natural polymer comprising a glycosaminoglycan.

15. The scaffold of claim 14 , wherein said glycosaminoglycan is hyaluronic acid or sodium hyaluronate.

16. The scaffold of claim 1 , wherein said first phase or said second phase further comprises a cytokine, a bone morphogenetic protein (BMP), a chelator, a therapeutic compound, or an antibiotic, or any combination thereof.

17. The scaffold of claim 16 , wherein said therapeutic compound comprises an antiinflammatory compound, an anti-infective compound, a growth factor, a pro-angiogenic factor or a combination thereof.

18. The scaffold of claim 1 , wherein said first phase or said second phase is seeded with cells that comprise mesenchymal stem cells, osteoblasts, osteocytes, osteoclasts, chondroblasts, chondrocytes, fibroblasts, or a combination thereof.

19. The scaffold of claim 1 , wherein said scaffold is cylindrical in shape and has a diameter of about 5-15 mm, and a height of about 5-25 mm.

20. The scaffold of claim 1 , wherein said cells are said bone marrow cells.

21. The scaffold of claim 1 , wherein said cells are said precursor cells derived from adipose tissue.

22. The scaffold of claim 1 , wherein said cells are both said bone marrow cells and said precursor cells derived from adipose tissue.

23. A method of inducing or enhancing repair, regeneration or enhancement of formation of cartilage, bone or a combination thereof, said method comprising implanting in a subject, the scaffold of claim 1 within a site in need of repair, regeneration or enhancement of formation of cartilage, bone or a combination thereof.

24. The method of claim 23 , wherein said method comprises exposing said site of cartilage repair, and optionally exposing bone tissue located proximally to the site of cartilage repair in said subject prior to implanting said scaffold.

25. The method of claim 24 , further comprising the step of affixing at least a portion of said scaffold within bone located proximally to said site of cartilage repair.

26. The method of claim 23 , further comprising promoting adhesion, proliferation or differentiation, or a combination thereof, of mesenchymal stem cells that are attracted to or provided with said scaffold, as a result of said implanting.

27. The method of claim 25 , further comprising seeding said scaffold with mesenchymal stem cells prior to said implanting.

28. The method of claim 25 , wherein said subject is afflicted with a cartilage and/or bone defect or disorder or disease.

29. The method of claim 25 , wherein said subject is a human subject.

30. The method of claim 25 , wherein said subject is an animal subject.

31. The method of claim 25 , wherein said cartilage defect or disorder comprises a full or partial thickness articular cartilage defect; osteochondral defect; osteoarthritis, a joint defect or a defect resulting from trauma, sports, or repetitive stress.

32. The method of claim 25 , wherein said scaffold is positioned such that said second phase is implanted within or proximally to bone tissue and said first phase is implanted within or proximally to cartilage tissue.

Assignments (3)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT REEL 060633, FRAME 0207 Recorded Oct 23, 2023
From: ELRON VENTURES LTD., AS SECURITYHOLDER REPRESENTATIVE, ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: CARTIHEAL (2009) LTD.
Reel/Frame 065320/0248 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 12, 2022
From: CARTIHEAL (2009) LTD.
To: ELRON VENTURES LTD., AS ADMINISTRATIVE AGENT
Reel/Frame 060633/0207 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2018
From: ALTSCHULER, NIR; VAGO, RAZI
To: CARTIHEAL (2009) LTD.
Reel/Frame 046499/0464 →
Continuity (6)
Continuation 15057796 · Mar 1, 2016
Continuation 14302184 · Jun 11, 2014
Continuation 13378474
Provisional Application 61187081 · Jun 15, 2009
Provisional Application 61252800 · Oct 19, 2009
Related Publication 20180339081A1 · Nov 29, 2018
Cited By (4)
US 12,350,159 US 12,357,465 US 12,447,233 US 12,508,343